Back to search

University of Thessaly (UTH)

Μελέτη πολυμορφισμών ανοσορυθμιστικών κυτοκινών σε ασθενείς με ψωρίαση και άλλες δερματολογικές παθήσεις

Abstract

dc:description

Introduction: Psoriasis is a chronic autoimmune inflammatory skin disease with varying responses to different treatments, influenced by genetic, immunological, and environmental factors. Advances in the field of pharmacogenomics promise the personalization of treatment by identifying biomarkers that can predict the therapeutic efficacy of each drug for individual patients. Objectives: The primary goal of this study is to identify genetic polymorphisms associated with treatment response to apremilast and secukinumab and evaluate their predictive value in therapeutic outcomes. Specifically, this study aims to investigate the impact of genetic polymorphisms on psoriasis patients treated with apremilast or secukinumab while simultaneously assessing immunological parameters (cellular subpopulations) in peripheral blood as functional biomarkers of treatment response. Additionally, another objective is to detect these polymorphisms in potential treatment candidates using a simple and cost-effective method. Methods: Next-generation sequencing (NGS) protocols to identify polymorphisms associated with response to treatment, and flow cytometry were employed to assess immune cell populations and their functional responses. Furthermore, a specialized PCR protocol was developed for selected polymorphisms, incorporating a dual-primer approach to facilitate future identification in clinical practice. Results: Key loci and specific single nucleotide polymorphisms (SNPs) are associated with responses to apremilast treatment. Specifically, response to apremilast was associated with 64 SNPs with p <0.05 and 10 SNPs with a strongly significant statistical association with p ≤0.01 which were rs322144, rs12745871, rs12118088, rs2815378, rs62128111, rs8108865, rs4808781, rs16887824, rs295943, rs1203844. An additional 15 SNPs were identified within the PDE4B, PDE4D, and CYP3A4 intronic regions. Concerning the patients who responded to secukinumab, two polymorphisms were associated with good response, rs8193036 and rs2275913. Based on this association and after the flow cytometry results, five patients treated with secukinumab were selected to be genotyped with the specific PCR protocol combining 2 primers in a single PCR reaction. This detected the presence of these polymorphisms in patients that have associated with a good response to secukinumab, acting as proof of principle, and highlighted the different reduction in the proportion of Th17 subpopulation among carriers of polymorphisms. Conclusions: Genetic polymorphisms associated with psoriasis treatment responses to apremilast and secukinumab were identified, alongside an evaluation of the functional capacity of cytokine responses. A user-friendly dual-primer PCR protocol was developed for the simultaneous detection of rs8193036 and rs2275913, saving both time and resources. This strategy could be expanded to other genetic polymorphisms, contributing to personalized medicine, and potentially integrating into the therapeutic algorithm for psoriasis, particularly for patients being considered for secukinumab treatment. The findings highlight the potential of using genetic markers and immunological parameters from peripheral blood to predict treatment outcomes and guide personalized therapeutic strategies. The development of a specialized PCR reaction with two primers for rs8193036 and rs2275913 represents a practical and efficient tool for genotype analysis, with direct applications in clinical practice. These methods may improve prognosis and foster individualized treatment approaches for psoriasis, enhancing the ability to tailor therapy based on each patient’s genetic profile.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Daponte, Athina-Ioanna
  • Δαπόντε, Αθηνά-Ιωάννα

Subjects

dc:subject × 21

Rights

Language dc:language
gre

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Daponte, Athina-Ioanna; Δαπόντε, Αθηνά-Ιωάννα. Μελέτη πολυμορφισμών ανοσορυθμιστικών κυτοκινών σε ασθενείς με ψωρίαση και άλλες δερματολογικές παθήσεις. University of Thessaly (UTH), 2025. http://hdl.handle.net/10442/hedi/60628